In this panel, you can perform survival analysis based on TCGA patients using specific drug treatment.

GEPIA performs differential analysis of Overall Survival (OS) or Progression-free Interval (PFI) between patients with or without using specific drugs. GEPIA uses Log-rank test, a.k.a the Mantel-Cox test, for hypothesis test.

Parameters:

• Drugs: Select a drug of interest. Both generic name and trade name are provided. If you are not sure which one to choose, see drug name standarization method.
• Methods: Select the OS or PFS survival response.
• Axis Units: Select Month or Day unit for plotting.
• Colors: Choose color to plot
• Datasets Selection: Select one or multiple cancer types and click "+" to build the dataset.

Notices:

• Only patients with drug treatment information are included. Thus the group without using selected drug refers to patients using other drugs.
• Since special treatment of blood tumor are not included (e.g. stem cell transplantation in DLBC), be careful to combine blood tumor and solid tumor into a uniformed dataset.
• Notice that there may not be sufficient cases for survial anaysis in single or limited cancer types.